Related Experiment Videos
Effects of plasma exchange on serum cholesterol levels in heterozygous familial hypercholesterolemia
Insights
Plasma exchange (PE) temporarily lowers cholesterol in familial hypercholesterolemia patients. While total cholesterol and HDL cholesterol decrease initially, long-term treatment showed no sustained cholesterol reduction.
Area of Science:
- Cardiology
- Metabolic Disorders
- Medical Technology
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder causing high cholesterol levels.
- Effective long-term cholesterol-lowering strategies for FH are crucial.
- Plasma exchange (PE) is a potential therapeutic option for managing severe hypercholesterolemia.
Purpose of the Study:
- To evaluate the cholesterol-lowering efficacy of plasma exchange (PE) in patients with heterozygous familial hypercholesterolemia.
- To assess the short-term and long-term effects of PE on serum lipid profiles.
- To determine the impact of PE on the total cholesterol/HDL cholesterol ratio.
Main Methods:
- Seven patients with heterozygous familial hypercholesterolemia participated.
- A treatment protocol involved one plasma exchange (PE) every three weeks for 27 weeks.
- Patients adhered to a cholesterol-lowering diet without additional medication.
Main Results:
- Plasma exchange (PE) resulted in a significant, temporary reduction in total cholesterol (Tot-c) and high-density lipoprotein cholesterol (HDL-c).
- HDL-c levels rebounded faster than Tot-c, creating a transiently favorable Tot-c/HDL-c ratio for 10-14 days.
- No sustained reduction in HDL-c or significant reduction in Tot-c was observed after 27 weeks of PE treatment.
Conclusions:
- Plasma exchange (PE) offers a temporary but not a sustained solution for lowering cholesterol in familial hypercholesterolemia.
- The transient improvement in the cholesterol ratio highlights the need for continuous or alternative therapeutic approaches.
- Further research is needed to explore long-term efficacy and optimal treatment strategies involving PE for FH.
Abstract:
This study describes the cholesterol-lowering effect of plasma exchange (PE) in seven patients with heterozygous familial hypercholesterolemia. All patients followed an identical protocol consisting of one PE per three weeks during 27 weeks. A cholesterol-lowering diet was prescribed in addition. No supporting cholesterol-lowering medication was given. PE leads to a momentary marked decrease in serum concentrations of both total cholesterol (Tot-c) and high density lipoprotein cholesterol (HDL-c). HDL-c concentration returns more rapidly to the plateau value than Tot-c concentration resulting in a transient favourable Tot-c/HDL-c ratio that disappears after 10-14 days. No reducing or increasing effect of PE on HDL-c concentration was observed after 27 weeks of treatment. Nor was any convincing reducing effect on Tot-c concentration observed.